These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10888366)

  • 1. Role of TNF-alpha in high-dose antigen therapy in experimental autoimmune neuritis: inhibition of TNF-alpha by neutralizing antibodies reduces T-cell apoptosis and prevents liver necrosis.
    Weishaupt A; Gold R; Hartung T; Gaupp S; Wendel A; Brück W; Toyka KV
    J Neuropathol Exp Neurol; 2000 May; 59(5):368-76. PubMed ID: 10888366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schwann cell apoptosis in experimental autoimmune neuritis of the Lewis rat and the functional role of tumor necrosis factor-alpha.
    Weishaupt A; Brück W; Hartung T; Toyka KV; Gold R
    Neurosci Lett; 2001 Jun; 306(1-2):77-80. PubMed ID: 11403962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticosteroids modulate antigen-induced T cell apoptosis in experimental autoimmune neuritis and cause T cell proliferation in situ.
    Weishaupt A; Schönrock LM; Stienekemeier M; Toyka KV; Gold R
    Acta Neuropathol; 2001 Jul; 102(1):75-82. PubMed ID: 11547954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intravenous immunoglobulins on T cell and oligodendrocyte apoptosis in high-dose antigen therapy in experimental autoimmune encephalomyelitis.
    Weishaupt A; Kuhlmann T; Schönrock LM; Toyka KV; Brück W; Gold R
    Acta Neuropathol; 2002 Oct; 104(4):385-90. PubMed ID: 12200625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance and susceptibility to experimental autoimmune neuritis in Sprague-Dawley and Lewis rats correlate with different levels of autoreactive T and B cell responses to myelin antigens.
    Zhu J; Zou LP; Bakhiet M; Mix E
    J Neurosci Res; 1998 Nov; 54(3):373-81. PubMed ID: 9819142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of Rolipram in experimental autoimmune neuritis: protection is associated with down-regulation of IFN-gamma and inflammatory chemokines as well as up-regulation of IL-4 in peripheral nervous system.
    Abbas N; Zou LP; Pelidou SH; Winblad B; Zhu J
    Autoimmunity; 2000 Sep; 32(2):93-9. PubMed ID: 11078155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of experimental autoimmune neuritis by leflunomide.
    Korn T; Toyka K; Hartung HP; Jung S
    Brain; 2001 Sep; 124(Pt 9):1791-802. PubMed ID: 11522581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen therapy eliminates T cell inflammation by apoptosis: effective treatment of experimental autoimmune neuritis with recombinant myelin protein P2.
    Weishaupt A; Gold R; Gaupp S; Giegerich G; Hartung HP; Toyka KV
    Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1338-43. PubMed ID: 9037054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of acute phase and inhibition of chronic phase of experimental autoimmune neuritis in Lewis rats by intranasal administration of recombinant mouse interleukin 17: potential immunoregulatory role.
    Pelidou SH; Zou LP; Deretzi G; Oniding C; Mix E; Zhu J
    Exp Neurol; 2000 May; 163(1):165-72. PubMed ID: 10785455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased lipocortin-1 (annexin-1) expression in the sciatic nerve of Lewis rats with experimental autoimmune neuritis.
    Gold R; Oelschläger M; Pepinsky RB; Sommer C; Hartung HP; Toyka KV
    Acta Neuropathol; 1999 Dec; 98(6):583-9. PubMed ID: 10603033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rolipram suppresses experimental autoimmune neuritis and prevents relapses in Lewis rats.
    Zou LP; Deretzi G; Pelidou SH; Levi M; Wahren B; Quiding C; van der Meide P; Zhu J
    Neuropharmacology; 2000 Jan; 39(2):324-33. PubMed ID: 10670428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of inducible nitric oxide synthase and tumor necrosis factor-alpha in the peripheral nervous system of Lewis rats during ascending paresis and spontaneous recovery from experimental autoimmune neuritis.
    De La Hoz CL; Castro FR; Santos LM; Langone F
    Neuroimmunomodulation; 2010; 17(1):56-66. PubMed ID: 19816058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effect of transforming growth factor-beta 2 on actively induced EAN but not adoptive transfer EAN.
    Jung S; Schluesener HJ; Schmidt B; Fontana A; Toyka KV; Hartung HP
    Immunology; 1994 Dec; 83(4):545-51. PubMed ID: 7533133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of experimental autoimmune neuritis by an antibody to the lymphocyte function-associated antigen-1.
    Archelos JJ; Mäurer M; Jung S; Miyasaka M; Tamatani T; Toyka KV; Hartung HP
    Lab Invest; 1994 May; 70(5):667-75. PubMed ID: 8196363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous glucocorticosteroid treatment augments apoptosis of inflammatory T cells in experimental autoimmune neuritis (EAN) of the Lewis rat.
    Zettl UK; Gold R; Toyka KV; Hartung HP
    J Neuropathol Exp Neurol; 1995 Jul; 54(4):540-7. PubMed ID: 7602327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment and prevention of experimental autoimmune neuritis with superagonistic CD28-specific monoclonal antibodies.
    Schmidt J; Elflein K; Stienekemeier M; Rodriguez-Palmero M; Schneider C; Toyka KV; Gold R; Hünig T
    J Neuroimmunol; 2003 Jul; 140(1-2):143-52. PubMed ID: 12864982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental allergic neuritis: cytolysin mRNA expression is upregulated in lymph node cells during convalescence.
    Zhu J; Bai XF; Mix E; Link H
    J Neuroimmunol; 1997 Sep; 78(1-2):108-16. PubMed ID: 9307234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention and therapy of experimental autoimmune neuritis by an antibody against T cell receptors-alpha/beta.
    Jung S; Krämer S; Schluesener HJ; Hünig T; Toyka K; Hartung HP
    J Immunol; 1992 Jun; 148(12):3768-75. PubMed ID: 1376340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of experimental autoimmune neuritis by nasal administration of P2 protein peptide 57-81.
    Zhu J; Deng GM; Levi M; Wahren B; Diab A; van der Meide PH; Link H
    J Neuropathol Exp Neurol; 1998 Mar; 57(3):291-301. PubMed ID: 9600221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF-alpha receptor 1 deficiency reduces antigen-presenting capacity of Schwann cells and ameliorates experimental autoimmune neuritis in mice.
    Mao XJ; Zhang XM; Zhang HL; Quezada HC; Mix E; Yang X; Winblad B; Adem A; Zhu J
    Neurosci Lett; 2010 Feb; 470(1):19-23. PubMed ID: 20035831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.